Signe Borgquist
21 – 30 of 171
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer
(
- Contribution to journal › Article
-
Mark
Aquaporin-5 in breast cancer
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Mammographic density as an image-based biomarker of therapy response in neoadjuvant-treated breast cancer patients
(
- Contribution to journal › Article
-
Mark
CYP2D6 genotype predicts tamoxifen discontinuation and drug response : a secondary analysis of the KARISMA trial
(
- Contribution to journal › Article
-
Mark
Aquaporins in pancreatic ductal adenocarcinoma
(
- Contribution to journal › Scientific review
-
Mark
High CYP27A1 expression is a biomarker of favorable prognosis in premenopausal patients with estrogen receptor positive primary breast cancer
(
- Contribution to journal › Article
-
Mark
Prognostic impact of tumor-specific insulin-like growth factor binding protein 7 (IGFBP7) levels in breast cancer : A prospective cohort study
(
- Contribution to journal › Article
-
Mark
Low thyroid hormone receptor alpha-2 (THRα-2) tumor expression is associated with unfavorable tumor characteristics and high breast cancer mortality
(
- Contribution to journal › Article
-
Mark
Overweight and prognosis in triple-negative breast cancer patients : a systematic review and meta-analysis
(
- Contribution to journal › Scientific review
-
Mark
Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer
(
- Contribution to journal › Article